Advertisement

HNO

, Volume 56, Issue 6, pp 603–608 | Cite as

„Field cancerization“ im oberen Aerodigestivtrakt

Überwachungsempfehlungen für Risikopersonen
  • H. ScherüblEmail author
  • J. Steinberg
  • C. Schwertner
  • P. Mir-Salim
  • U. Stölzel
  • E.-M. de Villiers
Übersichten

Zusammenfassung

Das Phänomen der multifokalen, syn- und metachronen Karzinogenese (bei stattgehabter Tabak- und oft auch Alkoholexposition) bezeichnete Slaughter 1953 als „field cancerization“ des oberen Aerodigestivtrakts. Patienten mit Kopf-Hals-Karzinomen tragen ein Risiko von 5–14%, an einem Plattenepithelzweitkarzinom der Speiseröhre oder der Bronchien zu erkranken. Die endoskopische Überwachung ermöglicht eine Früherkennung von ösophagealen Zweitneoplasien und eine frühe kurative Therapie. Standard ist hierbei die hochauflösende Videoösophagoskopie mit Lugol-Färbung; seit kurzem stehen mit der Narrow-band-imaging- (NBI-)Endoskopie und der Endomikroskopie 2 zusätzliche neue Techniken zur Verfügung. Die Überwachung von Kopf-Hals-Tumor-Patienten im Hinblick auf Zweitkarzinome der Lunge ist ebenfalls wünschenswert, bislang aber nicht etabliert. Umgekehrt sollen Patienten mit kurativ behandeltem Plattenepithelkarzinom der Lunge oder Speiseröhre regelmäßig pharyngolaryngoskopiert werden, da auch in diesem Bereich das Risiko von Zweitneoplasien etwa 10% beträgt. Patienten mit „field cancerization“ bedürfen also generell einer interdisziplinären Betreuung und Überwachung.

Schlüsselwörter

Multifokale Karzinogenese Ösophagusneoplasie Bronchialkarzinom Screening Kopf-Hals-Tumor 

Coincidental squamous cell cancers of the esophagus, head, and neck

Risk and screening

Abstract

The term “field cancerization” was coined by Slaughter in1953 when describing multifocal synchronous and metachronous carcinogenesis in the upper aerodigestive system. Patients suffering from head and neck cancer (HNC) have or develop a second esophageal squamous cell cancer (ESCC) or bronchial cancer (BC) in 5–14% of cases. When a second esophageal cancer occurs in a patient with HNC, the prognosis is generally determined by the ESCC, and, unfortunately, it is poor. Screening and surveillance by Lugol chromoesophagoscopy enable early detection and curative treatment of second esophageal neoplasias. Surveillance appears to result in a survival benefit for HNC patients. Vice versa, patients with ESCC or BC have a risk of about 10% for developing HNC. Periodic pharyngolaryngoscopy is recommended for curatively treated ESCC or BC patients. Patients with field cancerization should be surveilled by a multidisciplinary approach.

Keywords

Multifocal carcinogenesis Esophageal neoplasia Bronchial cancer Screening Head and neck tumor 

Notes

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Bairati I, Meyer F, Jobin E et al. (2006) Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 119: 2221–2224PubMedCrossRefGoogle Scholar
  2. 2.
    Bareiß D, Stabenow R, Müller R et al. (2002) Aktuelle Epidemiologie des Ösophagus- und des Kardiakarzinoms in Deutschland. Dtsch Med Wochenschr 127: 1367–1374 PubMedCrossRefGoogle Scholar
  3. 3.
    Cooper J, Pajak T, Rubin P et al. (1989) Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience. Int J Radiation Oncology Biol Phys 17: 449–456Google Scholar
  4. 4.
    De Villiers EM, Gunst K, Stein H, Scherübl H (2004). Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences. Int J Cancer 109: 253–258CrossRefGoogle Scholar
  5. 5.
    Dietz A (2006) Nicotine and the origin of cancer in the upper aerodigestive tract. HNO 54: 345–346PubMedCrossRefGoogle Scholar
  6. 6.
    Dubuc J, Legoux J, Winnock M et al. (2006) Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy 38: 690–695PubMedCrossRefGoogle Scholar
  7. 7.
    Hafkamp H, Manni J, Speel E (2004) Role of human papillomavirus in the development of head and neck squamous cell carcinomas. Acta Otolaryngol 124: 520–526PubMedCrossRefGoogle Scholar
  8. 8.
    Hoffmann A, Goetz M, Vieth M et al. (2006) Confocal laser endomicroscopy: technical status and current indications. Endoscopy 38: 1275–1283CrossRefGoogle Scholar
  9. 9.
    Hoffmann M, Gottschlich S, Görögh T et al. (2005) Human papillomaviruses in lymph node neck metastases of head and neck cancers. Acta Otolaryngol 125: 415–421PubMedGoogle Scholar
  10. 10.
    Homann N, Stickel F, Konig I et al. (2006) Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers. Int J Cancer 118: 1998–2002PubMedCrossRefGoogle Scholar
  11. 11.
    Horiuchi M, Makuuchi H, Machimura T, Tamura Y, Sakai M (1998) Survival benefit of screening for early oesophageal carcinoma in head and neck cancer patients. Dig Endosc 10: 110–115CrossRefGoogle Scholar
  12. 12.
    Kleinsasser N, Sassen A, Semmler M et al. (2006) Does nicotine add carcinogenic strain of tobacco smoke? HNO 54: 369–375PubMedCrossRefGoogle Scholar
  13. 13.
    Lee et al. (2007) Narrow band imaging endoscopy for early detection of second esophageal neoplasias in head and neck cancer patients. GI ASCO Orlando, USA 2007Google Scholar
  14. 14.
    Leon X, Quer M, Diez S et al. (1999) Second neoplasm in patients with head and neck cancer. Head Neck 21: 204–210PubMedCrossRefGoogle Scholar
  15. 15.
    Limburg P, Wei W, Ahnen D et al. (2005) Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology 129: 863–873PubMedCrossRefGoogle Scholar
  16. 16.
    Lin K, Patel S, Chu P et al. (2005) Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 27:1042–1048PubMedCrossRefGoogle Scholar
  17. 17.
    Maaser K, Däubler P, Barthel B et al. (2003) Esophageal squamous cell neoplasia in head and neck cancer patients. Upregulation of COX-2 during carcinogenesis. Br J Cancer 88: 1217–1222PubMedCrossRefGoogle Scholar
  18. 18.
    Makuuchi H (1996) Endoscopic mucosal resection for early oesophageal cancer. Indications and techniques. Dig Endosc 8: 175–179Google Scholar
  19. 19.
    Makuuchi H, Machimura T, Shimada H et al. (1996) Endoscopic screening for oesophageal cancer in 788 patients with head and neck cancers. Tokai Exp Clin Med 21: 139–145Google Scholar
  20. 20.
    Matsubara T, Yamada K, Nakagawa A (2003) Risk of second primary malignany after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21: 4336–4341PubMedCrossRefGoogle Scholar
  21. 21.
    Meyer V, Burtin P, Bour B et al. (1997) Endoscopic detection of early oesophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy? Gastrointest Endosc 45: 480–484PubMedCrossRefGoogle Scholar
  22. 22.
    Möschler O, Spahn T, Middelberg-Bisping C et al. (2006) Chromooendoscopy is a valuable tool for screening of high-risk patients with head and neck cancer for early detection of esophageal cancer. Digestion 73: 160–166PubMedCrossRefGoogle Scholar
  23. 23.
    Murakami S, Hashimoto T, Noguchi T et al. (1999) The utility of endoscopic screening for patients with esophageal or head and neck cancer. Dis Esophagus 12: 186–190PubMedCrossRefGoogle Scholar
  24. 24.
    Muto M, Hironika S, Natanabe M et al. (2002). Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 56: 517–521PubMedCrossRefGoogle Scholar
  25. 25.
    Petit T, Georges C, Jung G et al. (2001) Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma. Ann Oncol 12: 643–646PubMedCrossRefGoogle Scholar
  26. 26.
    Poppendieck J (1987) Incidence of multiple tumors in the upper aerodigestive tract. Routine panendoscopy? HNO 35: 19–23PubMedGoogle Scholar
  27. 27.
    Salaspuro V, Hietala J, Marvola M et al. (2006) Eliminating carcinogenic acetaldehyde by cysteine from saliva during smoking. Cancer Epidemiol Biomarkers Prev 15: 146–149PubMedCrossRefGoogle Scholar
  28. 28.
    Savary J, Grosjean P, Monnier P et al. (1998) Photodynamic therapy of early squamous cell carcinomas of the esophagus: A review of 31 cases. Endoscopy 30: 258–265PubMedGoogle Scholar
  29. 29.
    Scherübl H (2005) Pesquisa de neoplasias esofágicas secundarias en los pacientes con cáncer de cabeza y cuello. http://www.trabajosdistinguidos.com/oncologia/indiceonco165.phpGoogle Scholar
  30. 30.
    Scherübl H, Scherer H, Hoffmeister B (2002) Second esophageal cancers in head and neck cancer patients. N Engl J Med 346: 1416–1417PubMedCrossRefGoogle Scholar
  31. 31.
    Scherübl H, von Lampe B, Faiss S et al. (2002) Screening for oesophageal neoplasia in patients with head and neck cancer. Br J Cancer 86: 239–243PubMedCrossRefGoogle Scholar
  32. 32.
    Shiozaki H, Tahara H, Kobayashi K et al. (1990) Endoscopic screening of early oesophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer 66: 2068–2071PubMedCrossRefGoogle Scholar
  33. 33.
    Slaughter D, Southwick H, Smeikal W (1953) Field cancerization in oral stratified squamous epithelium. Cancer 6: 963–968PubMedCrossRefGoogle Scholar
  34. 34.
    Sutter A, Höpfner M, Huether A, Maaser K, Scherübl H (2006). Targeting the epidermal growth factor receptor by erlotinib (Tarceva) for the treatment of esophageal cancer. Int J Cancer 118:1814–1822PubMedCrossRefGoogle Scholar
  35. 35.
    Tincani A, Brandalise N, Altemani A et al. (2000) Diagnosis of superficial oesophageal cancer and dysplasia using endoscopic screening with a 2% Lugol dye solution in patients with head and neck cancer. Head Neck 22: 170–174PubMedCrossRefGoogle Scholar
  36. 36.
    Tsao A, Kim E, Hong W (2004) Chemoprevention of cancer. CA Cancer J Clin 54:150–180PubMedCrossRefGoogle Scholar
  37. 37.
    Visapaa J, Gotte K, Benesova M et al. (2004) Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C*1 allele, possibly due to salivary acetaldehyde. Gut 53: 871–876PubMedCrossRefGoogle Scholar
  38. 38.
    Waldfahrer F, Iro H (2002) Basic principles and concepts of enteral nutrition of ENT patients. HNO 50: 201–208PubMedCrossRefGoogle Scholar
  39. 39.
    Wang G, Abnet C, Shen Q et al. (2005) Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 54:187–192PubMedCrossRefGoogle Scholar
  40. 40.
    Watanabe A, Hosokawa M, Taniguchi M et al. (2003) Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer. Ann Thorac Surg 76:1699–1705PubMedCrossRefGoogle Scholar
  41. 41.
    Watanabe A, Hosokawa M, Taniguchi M et al. (2007) Head and neck cancer associated with esophageal cancer. Auris Nasus Larynx 34: 207–211PubMedCrossRefGoogle Scholar
  42. 42.
    Watanabe A, Tsujie H, Taniguchi M et al. (2006) Laryngoscopic detection of pharyngeal carcinoma in situ with narrowband imaging. Laryngoscope 116: 650–654PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag 2007

Authors and Affiliations

  • H. Scherübl
    • 1
    Email author
  • J. Steinberg
    • 1
  • C. Schwertner
    • 1
  • P. Mir-Salim
    • 2
  • U. Stölzel
    • 3
  • E.-M. de Villiers
    • 4
  1. 1.Klinik für Innere Medizin - Gastroenterologie und Gastrointestinale OnkologieVivantes-Klinikum Am UrbanBerlinDeutschland
  2. 2.HNO-KlinikVivantes-Klinikum im FriedrichshainBerlinDeutschland
  3. 3.Klinik für Gastroenterologie und InfektiologieKlinikumChemnitzDeutschland
  4. 4.Abteilung für Tumorvirus-CharakterisierungDKFZHeidelbergDeutschland

Personalised recommendations